Available Treatment Options Helps Decrease Melanoma Mortality Rate
Source: Dermatology Time, December 2022
New research suggests new pharmacological therapies are associated with a decrease in melanoma-related deaths.
Newly released research suggests that new treatments for cutaneous melanoma are responsible for a lower mortality rate among adult patients in the US.
Researchers at the University of Toledo College of Medicine and Life Science in Toledo, Ohio used a population-based cross-sectional study of patients with cutaneous melanoma from the Surveillance, Epidemiology, and End Results (SEER) database from 1975 to 2019. They found the melanoma mortality rate (MMR) decreased from 2013 to 2017 for the first time in the past 40 years in the US, based on the new treatment options that became available in 2013.